The global vaccine adjuvants market at a CAGR of almost 11% during the forecast period

by NASDAQ Market News January 13, 2020

NASDAQ Market News
Click here to email author

The global veterinary rapid tests market at a CAGR of almost 7% during the forecast period

Adaptive and Genentech Partner to Use clonoSEQ® Assay to Measure Minimal Residual Disease as a Primary Endpoint in Phase III Study of Chronic Lymphocytic Leukemia Patients

Ads